These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 11134254

  • 1. Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix.
    Martin J, Eynstone L, Davies M, Steadman R.
    J Am Soc Nephrol; 2001 Jan; 12(1):88-96. PubMed ID: 11134254
    [Abstract] [Full Text] [Related]

  • 2. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
    Phillips PA, McCarroll JA, Park S, Wu MJ, Pirola R, Korsten M, Wilson JS, Apte MV.
    Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
    [Abstract] [Full Text] [Related]

  • 3. Monocyte adhesion to mesangial matrix modulates cytokine and metalloproteinase production.
    Chana RS, Martin J, Rahman EU, Wheeler DC.
    Kidney Int; 2003 Mar; 63(3):889-98. PubMed ID: 12631069
    [Abstract] [Full Text] [Related]

  • 4. Soluble latent membrane-type 1 matrix metalloprotease secreted by human mesangial cells is activated by urokinase.
    Kazes I, Delarue F, Hagège J, Bouzhir-Sima L, Rondeau E, Sraer JD, Nguyen G.
    Kidney Int; 1998 Dec; 54(6):1976-84. PubMed ID: 9853262
    [Abstract] [Full Text] [Related]

  • 5. Identification and independent regulation of human mesangial cell metalloproteinases.
    Martin J, Knowlden J, Davies M, Williams JD.
    Kidney Int; 1994 Sep; 46(3):877-85. PubMed ID: 7996810
    [Abstract] [Full Text] [Related]

  • 6. Monocyte/mesangial cell interactions in high-glucose co-cultures.
    Menè P, Caenazzo C, Pugliese F, Cinotti GA, D'Angelo A, Garbisa S, Gambaro G.
    Nephrol Dial Transplant; 2001 May; 16(5):913-22. PubMed ID: 11328895
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of matrix proteins on the expression of matrix metalloproteinase-2, -9, and -14 and tissue inhibitors of metalloproteinases in human cytotrophoblast cells during the first trimester.
    Xu P, Wang Y, Piao Y, Bai S, Xiao Z, Jia Y, Luo S, Zhuang L.
    Biol Reprod; 2001 Jul; 65(1):240-6. PubMed ID: 11420245
    [Abstract] [Full Text] [Related]

  • 10. Fibronectin metabolism by human mesangial cells: effects of collagens.
    Cosio FG.
    Am J Physiol; 1993 Jan; 264(1 Pt 2):F106-19. PubMed ID: 8430822
    [Abstract] [Full Text] [Related]

  • 11. Regulation of extracellular matrix by mechanical stress in rat glomerular mesangial cells.
    Yasuda T, Kondo S, Homma T, Harris RC.
    J Clin Invest; 1996 Nov 01; 98(9):1991-2000. PubMed ID: 8903317
    [Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage.
    Keeling J, Herrera GA.
    Kidney Int; 2005 Oct 01; 68(4):1590-603. PubMed ID: 16164636
    [Abstract] [Full Text] [Related]

  • 13. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways.
    Esparza J, Vilardell C, Calvo J, Juan M, Vives J, Urbano-Márquez A, Yagüe J, Cid MC.
    Blood; 1999 Oct 15; 94(8):2754-66. PubMed ID: 10515879
    [Abstract] [Full Text] [Related]

  • 14. Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells.
    Anderson SS, Wu K, Nagase H, Stettler-Stevenson WG, Kim Y, Tsilibary EC.
    Cell Adhes Commun; 1996 Aug 15; 4(2):89-101. PubMed ID: 8937745
    [Abstract] [Full Text] [Related]

  • 15. Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen.
    Jacot TA, Striker GE, Stetler-Stevenson M, Striker LJ.
    Lab Invest; 1996 Dec 15; 75(6):791-9. PubMed ID: 8973474
    [Abstract] [Full Text] [Related]

  • 16. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1.
    Singh R, Song RH, Alavi N, Pegoraro AA, Singh AK, Leehey DJ.
    Exp Nephrol; 2001 Dec 15; 9(4):249-57. PubMed ID: 11423724
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
    Pugliese G, Pricci F, Romeo G, Pugliese F, Mené P, Giannini S, Cresci B, Galli G, Rotella CM, Vlassara H, Di Mario U.
    Diabetes; 1997 Nov 15; 46(11):1881-7. PubMed ID: 9356040
    [Abstract] [Full Text] [Related]

  • 18. Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP).
    Ailenberg M, Silverman M.
    Biochem J; 1996 Feb 01; 313 ( Pt 3)(Pt 3):879-84. PubMed ID: 8611170
    [Abstract] [Full Text] [Related]

  • 19. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P, Sähr H, Lehner B, Fischer C, Seebach E, Fellenberg J.
    BMC Cancer; 2016 Mar 15; 16():223. PubMed ID: 26979530
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells.
    Zahner G, Harendza S, Müller E, Wolf G, Thaiss F, Stahl RA.
    Kidney Int; 1997 Apr 15; 51(4):1116-23. PubMed ID: 9083277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.